Viewing Study NCT07244705


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-01-12 @ 4:26 AM
Study NCT ID: NCT07244705
Status: RECRUITING
Last Update Posted: 2025-11-24
First Post: 2025-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
Sponsor: Anbogen Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module